Medicine and Dentistry
Transplantation
100%
Cytomegalovirus
50%
Malignant Neoplasm
44%
Ribavirin
36%
Emergency Department
36%
Combination Therapy
33%
Mycobacterium Avium-Intracellulare Infection
33%
Respiratory Failure
29%
Diseases
27%
Infection
25%
Mycobacterium kansasii
25%
Disseminated Disease
22%
Human respiratory syncytial virus
20%
Antibiotics
20%
Gram-Negative Bacteria
19%
Mortality Rate
18%
Engraftment
18%
Hematopoietic Stem Cell Transplantation
16%
Breast Cancer
16%
Dirithromycin
16%
Respiratory Syncytial Virus Infection
16%
Nocardiosis
16%
Nocardia
16%
Respiratory Disease
16%
Immunoglobulin
16%
Adenovirus Infection
16%
Daptomycin
16%
Febrile Neutropenia
16%
Hematologic Malignancy
16%
Adverse Effect
16%
Leukemia
16%
Central Venous Catheter
16%
Pseudomonas
16%
Extrapulmonary Tuberculosis
16%
Bloodstream Infection
16%
Mycobacterium intracellulare
16%
Lung Granuloma
16%
Encephalitis
16%
Legionella
16%
Upper Respiratory Tract
16%
Immunity
16%
Venous Thromboembolism
16%
West Nile Virus
16%
Antiviral Therapy
13%
Immunosuppressive Treatment
12%
Virus Infection
8%
Physical Disease by Body Function
8%
Ganciclovir
8%
Antimycobacterial
8%
Mycobacterial Infection
8%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
72%
Respiratory Failure
44%
Diseases
41%
Imipenem
33%
Ribavirin
33%
Combination Therapy
33%
Cytomegalovirus
33%
Infection
32%
Cefepime
27%
Antibiotics
24%
Human respiratory syncytial virus
22%
Hematologic Malignancy
19%
Gram Negative Bacterium
19%
Foscarnet
19%
Dirithromycin
16%
Respiratory Syncytial Virus Infection
16%
Penicillinase
16%
Myeloma
16%
Extrapulmonary Tuberculosis
16%
Antiviral Therapy
16%
Breast Cancer
16%
Respiratory Tract
16%
Febrile Neutropenia
16%
Respiratory Tract Disease
16%
Immunoglobulin
16%
Cephalosporin Derivative
16%
Mycobacterium intracellulare
16%
Mycobacterium Tuberculosis
16%
Mycobacterium kansasii
16%
Atypical Mycobacteriosis
16%
Legionella
16%
Ceftazidime
13%
Amikacin
12%
Tuberculosis
12%
Aztreonam
11%
Meropenem
11%
Piperacillin Plus Tazobactam
11%
Ciprofloxacin
11%
Mortality Rate
10%
Neutropenia
10%
Immune Deficiency
8%
Verapamil
8%
Solid Malignant Neoplasm
8%
Viremia
8%
Ganciclovir
8%
Vancomycin
7%
Chemotherapy
5%
Adverse Event
5%
Antimicrobial Resistance
5%
Tobramycin
5%
Keyphrases
Cancer Patients
44%
In Cancer
36%
Marrow Transplantation
33%
Cytomegalovirus Pneumonia
33%
Transplant Recipients
33%
Imipenem
16%
Adverse Effects
16%
Nocardiosis
16%
Nocardia Bacteremia
16%
Comprehensive Cancer Center
16%
Neutropenic Fever
16%
Dirithromycin
16%
Pulmonary Disease
16%
Allogeneic Blood
16%
Leukemia
16%
Gram-negative Bacilli
16%
Immune-related Adverse Effects
16%
Emerging Problems
16%
Clinical Features
16%
Rapidly Growing Mycobacteria
16%
Emergency Department
16%
Radiological Features
16%
Significance Analysis
16%
Pulmonary Granulomas
16%
Immune Checkpoint Therapy
16%
Unusual Manifestation
16%
Legionella Pneumonia
16%
Cancer Center
16%
Central Venous Catheter
16%
Cancer Combination Therapy
16%
Catheter-related
16%
Mycobacterium Kansasii
16%
Adenovirus Infection
16%
CMV Pneumonia
16%
Adult Recipients
16%
Ciprofloxacin
14%
Emergency Department Visits
13%
Cefepime
11%
Piperacillin-tazobactam
11%
Aztreonam
11%
Meropenem
11%
Pneumonia
11%
Immunosuppressive Therapy
11%
Ceftazidime
11%
Mycobacterium Chelonae
10%
Mortality Rate
9%
Antibiotics
8%
Empiric Antibiotics
8%
Corticosteroid Exposure
8%
Adult Blood
8%
